Table 1 Basic information
From: The effect of loteprednol suspension eye drops after corneal transplantation
1 % prednisolone acetate eye drop group (n = 96) | 0.5 % loteprednol suspension eye drop group (n = 138) | P value | |
|---|---|---|---|
Age (years) | 51.03 ± 14.15 | 49.38 ± 15.77 | 0.413 |
Male, n (%) | 55 (57.29) | 94 (68.12) | 0.090 |
Surgical method, n (%) | 0.246 | ||
PKP | 54 (56.25) | 67 (48.55) | |
LKP | 42 (43.75) | 71 (51.45) | |
Preoperative diagnosis, n (%) | 0.468 | ||
Bullous keratopathy | 3 (3.13) | 2 (1.45) | |
Keratoconus | 14 (14.58) | 22 (15.94) | |
Corneal degeneration | 7 (7.29) | 5 (3.62) | |
Corneal mass | 2 (2.08) | 1 (0.72) | |
Corneal leukoplakia | 21 (21.88) | 28 (20.29) | |
Corneal dystrophy | 8 (8.33) | 4 (2.90) | |
Keratitis | 4 (4.17) | 11 (7.97) | |
Pseudopterygium | 1 (1.04) | 1 (0.72) | |
Non-infectious corneal ulcer | 3 (3.13) | 4 (2.90) | |
Infective corneal ulcer | 27 (28.13) | 53 (38.41) | |
Infectious corneal ulcer perforation | 6 (6.25) | 7 (5.07) | |
Preoperative IOP | 12.41 ± 2.90 | 12.28 ± 3.07 | 0.754 |
Preoperative BCVA | 2.04 ± 1.06 | 2.17 ± 1.09 | 0.339 |